NCT06892548 - A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer | Biotech Hunter

Enrollment

594

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

June 30, 2031

Conditions

Advanced Lung Cancer

Interventions

BIOLOGICAL

BNT324

Intravenous infusion

BIOLOGICAL

BNT327

Intravenous infusion

Trial Locations (12)

3021

RECRUITING

Sunshine Hospital, Saint Albans

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

31755

RECRUITING

Yeditepe University Medical School Hospital, Istanbul

90212

RECRUITING

Precision NextGen Oncology and Research Center, Beverly Hills

276001

RECRUITING

Linyi Cancer Hospital, Shandong

441021

RECRUITING

Xiangyang Central Hospital, Xiangyang

530021

RECRUITING

Guangxi Medical University Cancer Hospital, Nanning

07601

RECRUITING

John Theurer Cancer Center at Hackensack UMC, Hackensack

06100

RECRUITING

Hacettepe University Medical Faculty, Ankara

06105

RECRUITING

Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital, Ankara

BS2 8ED

RECRUITING

Bristol Haematology and Oncology Centre, Bristol

W1T 7HA

RECRUITING

University College London Hospital, London